Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual care

BACKGROUND: Randomized clinical trials showed the benefit of pharmacological and revascularization treatments in secondary prevention of myocardial infarction (MI), in selected population with highly controlled interventions. The objective of this study is to measure these treatments' impact on...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanasse, Alain, Courteau, Josiane, Niyonsenga, Théophile
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473199/
https://www.ncbi.nlm.nih.gov/pubmed/16674817
http://dx.doi.org/10.1186/1471-2261-6-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473199/
https://www.ncbi.nlm.nih.gov/pubmed/16674817
http://dx.doi.org/10.1186/1471-2261-6-21

Ejemplares similares